TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Monash IVF Group Ltd ( (AU:MVF) ) has shared an update.
Monash IVF Group Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, highlighting its commitment to transparency and accountability in its management and oversight practices. This announcement underscores the company’s dedication to maintaining high governance standards, which is crucial for its stakeholders and market reputation.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Limited operates in the healthcare industry, focusing on reproductive health services. The company provides in vitro fertilization (IVF) and related fertility treatments, positioning itself as a key player in the fertility services market.
Average Trading Volume: 4,245,281
Technical Sentiment Signal: Sell
Current Market Cap: A$315.6M
Learn more about MVF stock on TipRanks’ Stock Analysis page.